Furthermore, the expression of ZKSCAN3-shRNA profoundly inhibits tumor growth in mice harboring breast cancer xenografts, indicating that suppressing ZKSCAN3 effectively impedes the Akt/mTOR signaling pathway by suppressing the expression of p-Akt and p-mTOR proteins in breast cancer cells. Here, AKT1 is linked to breast carcinoma.